Jeonjinbio Co., Ltd. (KOSDAQ: 110020)

Jeonjinbio Balance Sheet

Financials in millions KRW. Fiscal year is January - December.

Fiscal Year	TTM	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019
Period Ending	Sep 30, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019
Cash & Equivalents	5,325	1,692	1,334	15,306	8,922	4,162
Short-Term Investments	761.26	-	-	-	-	-
Cash & Short-Term Investments	6,086	1,692	1,334	15,306	8,922	4,162
Cash Growth	130.60%	26.83%	-91.28%	71.54%	114.37%	-21.95%
Accounts Receivable	2,382	2,803	724.02	205.04	93.8	12.11
Other Receivables	8.41	5.42	5.98	4.15	87.22	7.52
Receivables	2,391	2,808	1,330	209.19	181.02	19.63
Inventory	1,645	1,746	1,982	602.35	341.57	332.03
Prepaid Expenses	11.95	8.07	57.1	7.76	285.1	9.55
Other Current Assets	23.46	1,511	52.83	33.04	256.87	9.43
Total Current Assets	10,158	7,767	4,756	16,158	9,987	4,533
Property, Plant & Equipment	9,450	9,765	10,948	7,997	8,048	1,109
Long-Term Investments	-	-	-0	-0	0	16.64
Other Intangible Assets	23.32	71.88	80.62	58.36	72.7	56.2
Long-Term Deferred Charges	-	-	636.91	552.08	488.95	579.49
Other Long-Term Assets	60.2	100.28	1,503	52.32	98.03	117.21
Total Assets	19,691	17,704	17,924	24,817	18,695	6,411
Accounts Payable	158.66	239.75	139.18	47.85	19.95	1.61
Accrued Expenses	660.17	521.74	485.06	337.31	321.58	399.38
Short-Term Debt	-	5,309	4,583	7,401	-	-
Current Portion of Long-Term Debt	-	-	-	-	5,107	-
Current Portion of Leases	365.03	288.27	1,089	7.5	31.38	202.55
Other Current Liabilities	854.16	4,854	1,651	6,185	1,863	52.73
Total Current Liabilities	2,038	11,213	7,947	13,979	7,343	656.27
Long-Term Debt	-	-	-	-	-	2,393
Long-Term Leases	-	-	288.27	-	7.04	117.78
Other Long-Term Liabilities	-	43.52	63.44	41.17	63	27.69
Total Liabilities	2,276	11,484	8,359	14,022	7,413	3,513
Common Stock	4,529	3,742	3,420	3,171	3,021	2,398
Additional Paid-In Capital	42,313	35,585	32,955	31,407	29,911	18,722
Retained Earnings	-28,738	-32,419	-25,900	-22,872	-20,746	-17,312
Comprehensive Income & Other	-688.68	-688.68	-910.12	-910.12	-904.91	-910.08
Total Common Equity	17,415	6,220	9,565	10,796	11,282	2,898
Shareholders' Equity	17,415	6,220	9,565	10,796	11,282	2,898
Total Liabilities & Equity	19,691	17,704	17,924	24,817	18,695	6,411
Total Debt	365.03	5,597	5,960	7,409	5,146	2,713
Net Cash (Debt)	5,721	-3,904	-4,625	7,897	3,777	1,449
Net Cash Growth	-	-	-	109.09%	160.63%	-53.23%
Net Cash Per Share	697.72	-535.98	-702.78	1273.53	774.52	305.17
Filing Date Shares Outstanding	9.06	7.48	6.84	6.34	6.04	4.8
Total Common Shares Outstanding	9.06	7.48	6.84	6.34	6.04	4.8
Working Capital	8,120	-3,446	-3,191	2,179	2,644	3,876
Book Value Per Share	1922.49	831.11	1398.45	1702.42	1867.27	604.35
Tangible Book Value	17,392	6,148	9,485	10,737	11,209	2,842
Tangible Book Value Per Share	1919.91	821.51	1386.67	1693.21	1855.23	592.64
Land	-	3,041	3,041	3,041	3,041	-
Buildings	-	3,568	3,568	3,568	3,568	-
Machinery	-	3,008	2,206	1,565	1,265	979.32
Construction In Progress	-	268	545.59	-	221.91	275

Source: S&P Capital IQ. Standard template. Financial Sources.